GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 9:00 AM ISTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus Medical Dialogues Bureau30 April 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
Using AI to detect mental health disorders likely to be counterproductive Medical Dialogues Bureau30 April 2019 9:00 AM ISTAI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
Trump to keep fighting opioids 'until our job is done' Medical Dialogues Bureau28 April 2019 9:00 AM ISTWhile prescription opioids initially accounted for most deaths, the epidemic is now driven by illicit heroin and fentanyl.ATLANTA: President Donald...
Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets Medical Dialogues Bureau26 April 2019 8:59 AM ISTPhentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study Farhat Nasim20 April 2019 10:00 AM ISTThe drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
New York sues billionaire family behind maker of OxyContin Garima30 March 2019 9:00 AM ISTNEW YORK: New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments...
Purdue Pharma agrees to pay $270 million to settle opioid case Medical Dialogues Bureau28 March 2019 9:15 AM ISTPurdue Pharma introduced OxyContin in the 1990s and marketed it hard to doctors, making tens of billions of dollars from the drug. But the company has...
February has been a month of achievements, robust initiatives and success at AMRI Hospitals Medical Dialogues Bureau26 March 2019 9:05 AM ISTNew Delhi: With an utmost commitment towards delivering the best medical services, AMRI Hospitals, Bhubaneshwar, has always been at the forefront of...
USFDA accepts Allergan license applications to expand Botox label Farhat Nasim11 March 2019 9:30 AM IST"The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
Allergan depression drug fails trial, loses over Rs 100 crore expected sales Farhat Nasim8 March 2019 9:00 AM ISTStanicky said the data was the most anticipated release of the year and likely means that Allergan will lose what had been expected to be a $1 billion...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
